tiprankstipranks
Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch
PremiumThe FlyJazz upgraded to Overweight at Morgan Stanley after Ziihera launch
15d ago
ALX Oncology announces results from Phase 1b/2 trial
Premium
The Fly
ALX Oncology announces results from Phase 1b/2 trial
17d ago
Jazz Pharmaceuticals’ Ziihera now included in updated NCCN guidelines
Premium
The Fly
Jazz Pharmaceuticals’ Ziihera now included in updated NCCN guidelines
22d ago
Zymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera
PremiumThe FlyZymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera
1M ago
Jazz Pharmaceuticals announces FDA approval of Ziihera in BTC
Premium
The Fly
Jazz Pharmaceuticals announces FDA approval of Ziihera in BTC
1M ago
Jazz Pharmaceuticals price target raised to $162 from $154 at Baird
Premium
The Fly
Jazz Pharmaceuticals price target raised to $162 from $154 at Baird
1M ago
Jazz Pharmaceuticals price target lowered to $190 from $200 at Barclays
PremiumThe FlyJazz Pharmaceuticals price target lowered to $190 from $200 at Barclays
2M ago
Zymeworks upgraded to Outperform from Market Perform at Leerink
Premium
The Fly
Zymeworks upgraded to Outperform from Market Perform at Leerink
2M ago
Jazz Pharmaceuticals Reports Strong Q3 2024 Growth
Premium
Company Announcements
Jazz Pharmaceuticals Reports Strong Q3 2024 Growth
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100